Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Impact of lockdown during COVID-19 pandemic on physical activity and arrhythmia burden in heart failure patients

J. Schmitt, B. Wenzel, B. Brüsehaber, I. Anguera, J. de Sousa, G. Nölker, A. Bulava, P. Marques, R. Hatala, G. Golovchiner, J. Meyhöfer, M. Ilan, On behalf of the BIO|STREAM.HF investigators

. 2022 ; 45 (4) : 471-480. [pub] 20220117

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019045

BACKGROUND: Restricted outdoor activity during COVID-19 related lockdown may accelerate heart failure (HF) progression and thereby increase cardiac arrhythmias. We analyzed the impact of March/April 2020 lockdown on physical activity and arrhythmia burden in HF patients treated with cardiac resynchronization therapy (CRT) devices with daily, automatic remote monitoring (RM) function. METHODS: The study cohort included 405 HF patients enrolled in Observation of Clinical Routine Care for Heart Failure Patients Implanted with BIOTRONIK CRT Devices (BIO|STREAM.HF) registry in 16 countries, who had left ventricular ejection fraction (LVEF) ≤40% (mean 28.2 ± 6.6%) and NYHA class II/III/IV (47.9%/49.6%/2.5%) before CRT pacemaker/defibrillator implantation. The analyzed RM data comprised physical activity detected by accelerometer, mean heart rate and nocturnal rate, PP variability, percentage of biventricular pacing, atrial high rate episode (AHRE) burden, ventricular extrasystoles and tachyarrhythmias, defibrillator shocks, and number of implant interrogations (i.e., follow-ups). Intraindividual differences in RM parameters before (4-week period) versus during (4-week period) lockdown were tested for statistical significance and independent predictors were identified. RESULTS: There was a significant relative change in activity (mean -6.5%, p < .001), AHRE burden (+17%, p = .013), and follow-up rate (-75%, p < .001) during lockdown, with no significant changes in other RM parameters. Activity decreased by ≥8 min/day in 46.5% of patients; predictors were higher LVEF, lower NYHA class, no defibrillator indication, and more activity before lockdown. AHRE burden increased by ≥17 min/day in 4.7% of patients; predictors were history of atrial fibrillation, higher LVEF, higher body mass index, and activity decrease during lockdown. CONCLUSION: Unfavorable changes in physical activity, AHRE burden, and follow-up rate were observed during lockdown, but not in ventricular arrhythmia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019045
003      
CZ-PrNML
005      
20220804135319.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pace.14443 $2 doi
035    __
$a (PubMed)34997979
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Schmitt, Jörn $u University Hospital Giessen and Marburg, Giessen, Germany $1 https://orcid.org/0000000254125656
245    10
$a Impact of lockdown during COVID-19 pandemic on physical activity and arrhythmia burden in heart failure patients / $c J. Schmitt, B. Wenzel, B. Brüsehaber, I. Anguera, J. de Sousa, G. Nölker, A. Bulava, P. Marques, R. Hatala, G. Golovchiner, J. Meyhöfer, M. Ilan, On behalf of the BIO|STREAM.HF investigators
520    9_
$a BACKGROUND: Restricted outdoor activity during COVID-19 related lockdown may accelerate heart failure (HF) progression and thereby increase cardiac arrhythmias. We analyzed the impact of March/April 2020 lockdown on physical activity and arrhythmia burden in HF patients treated with cardiac resynchronization therapy (CRT) devices with daily, automatic remote monitoring (RM) function. METHODS: The study cohort included 405 HF patients enrolled in Observation of Clinical Routine Care for Heart Failure Patients Implanted with BIOTRONIK CRT Devices (BIO|STREAM.HF) registry in 16 countries, who had left ventricular ejection fraction (LVEF) ≤40% (mean 28.2 ± 6.6%) and NYHA class II/III/IV (47.9%/49.6%/2.5%) before CRT pacemaker/defibrillator implantation. The analyzed RM data comprised physical activity detected by accelerometer, mean heart rate and nocturnal rate, PP variability, percentage of biventricular pacing, atrial high rate episode (AHRE) burden, ventricular extrasystoles and tachyarrhythmias, defibrillator shocks, and number of implant interrogations (i.e., follow-ups). Intraindividual differences in RM parameters before (4-week period) versus during (4-week period) lockdown were tested for statistical significance and independent predictors were identified. RESULTS: There was a significant relative change in activity (mean -6.5%, p < .001), AHRE burden (+17%, p = .013), and follow-up rate (-75%, p < .001) during lockdown, with no significant changes in other RM parameters. Activity decreased by ≥8 min/day in 46.5% of patients; predictors were higher LVEF, lower NYHA class, no defibrillator indication, and more activity before lockdown. AHRE burden increased by ≥17 min/day in 4.7% of patients; predictors were history of atrial fibrillation, higher LVEF, higher body mass index, and activity decrease during lockdown. CONCLUSION: Unfavorable changes in physical activity, AHRE burden, and follow-up rate were observed during lockdown, but not in ventricular arrhythmia.
650    12
$a fibrilace síní $x terapie $7 D001281
650    12
$a COVID-19 $7 D000086382
650    12
$a srdeční resynchronizační terapie $7 D058406
650    _2
$a kontrola infekčních nemocí $7 D003140
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a cvičení $7 D015444
650    12
$a srdeční selhání $x epidemiologie $x terapie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $7 D058873
650    _2
$a tepový objem $7 D013318
650    _2
$a výsledek terapie $7 D016896
650    _2
$a funkce levé komory srdeční $7 D016277
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wenzel, Beate $u Biotronik SE & CO. KG, Berlin, Germany
700    1_
$a Brüsehaber, Bernd $u Biotronik SE & CO. KG, Berlin, Germany
700    1_
$a Anguera, Ignasi $u University Hospital Bellvitge, Barcelona, Spain
700    1_
$a de Sousa, Joao $u Hospital de Santa Maria, Lisbon, Portugal
700    1_
$a Nölker, Georg $u Christliches Klinikum Unna, Unna, Germany
700    1_
$a Bulava, Alan $u Ceske Budejovice Hospital, Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice, Ceske Budejovice, Czech Republic
700    1_
$a Marques, Pedro $u Hospital de Santa Maria, Lisboa, Portugal
700    1_
$a Hatala, Robert $u National Institute of Cardiovascular Diseases, Bratislava, Slovakia
700    1_
$a Golovchiner, Gregory $u Rabin Medical Center, Petach-Tikva, Israel
700    1_
$a Meyhöfer, Jürgen $u Maria Heimsuchung Caritas-Klinik Pankow, Berlin, Germany
700    1_
$a Ilan, Michael $u Shaare Zedek Medical Center, Jerusalem, Israel
710    2_
$a On behalf of the BIO|STREAM.HF investigators
773    0_
$w MED00003671 $t Pacing and clinical electrophysiology : PACE $x 1540-8159 $g Roč. 45, č. 4 (2022), s. 471-480
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34997979 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135312 $b ABA008
999    __
$a ok $b bmc $g 1822591 $s 1170288
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 45 $c 4 $d 471-480 $e 20220117 $i 1540-8159 $m Pacing and clinical electrophysiology $n Pacing Clin Electrophysiol $x MED00003671
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace